The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD. Blood Adv. 2025 08 15.
Akahoshi Y, Portelli J, Katsivelos N, Louloudis IE, Aguayo-Hiraldo PI, Ayuk FA, Chanswangphuwana C, Choe HK, Eder M, Etra AM, Hexner EO, Kitko CL, Kraus S, Merli P, Olson TS, Pasic I, Qayed M, Reshef R, Schechter-Finkelstein T, Marx J, Ullrich E, Vasova I, Weber D, Wölfl M, Zeiser R, Baez J, Eng GW, Gleich S, Kowalyk SM, Morales G, Spyrou N, Young R, DeFilipp Z, Hogan WJ, Nakamura R, Levine JE, Ferrara JLM. PMID: 40815797.
View in:
PubMed Mentions: Fields:
Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplant. 2025 Mar; 60(3):406-411.
Merli P, Jodele S, Cook E, Myers KC, Lane A, Ryhänen S, Cefalo MP, Quagliarella F, Davies SM, Teusink-Cross A, Aguayo-Hiraldo P, Alexander JL, Szabolcs P, Kohorst M, Corsetti T, Locatelli F, Sabulski A. PMID: 39627345.
View in:
PubMed Mentions: Fields: